Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They've been selling better mousetraps for over 100 years. I would expect at some point they would simply include it in their tiered services or make some kind of inclusive offer directly to their membership.
Although I gotta say, UL offers one heck of a platform with unparalleled global acceptance. Of course money talks, but this IMO seems more than just another "flyer". UL gets it, or so I hope...
Five dead, nearly 200 sick in E. coli outbreak from lettuce. And investigators are stumped. The Washington Post 6/3/18 Kristine Guerra
Anti-Copying Technology for 3D Printing: A Survey
by John Hornick | May 30, 2018
Yes I recall, though at this juncture I'd rather be aligned with Industry over Academia if that's possible. The "Pilot-MoU-Contract" route to commercialization.
Down the rabbit hole, to the core...
GKN is a global engineering group, operating from more than 150 manufacturing locations in over 30 countries. GKN has been a global leader in AM for decades, with aerospace components produced, certified and flying on seven major platforms today, as well as a world-leader in AM automotive parts and a specialist powder producer.
http://www.conceptlaserinc.com/en/news.html?tx_btnews_anzeige%5Banzeige%5D=202&tx_btnews_anzeige%5Baction%5D=show&tx_btnews_anzeige%5Bcontroller%5D=Anzeige&cHash=366883d667404bec06015490a32d5759
Additive Manufacturing in 2040: Powerful Enabler, Disruptive Threat
A recent RAND Report with one proactive Policy consideration we could certainly advance.
AFTER HOURS
$1.75
UP
0.26 - 17.45%
*Delayed - data as of 05/03/2018 17:35:14
VOLUME:18,972
https://www.nasdaq.com/symbol/apdn/after-hours
Applied DNA Reports Fiscal Second Quarter 2018 Financial Results
-Submits Drug Master File to FDA for Administrative Review-
-Signs $2.5 Million in Non-Textile Contracts-
-Company to Hold Conference Call and Webcast Today, Thursday, May 3, 2018 at 4:30 PM ET-
May 03, 2018 04:05 PM Eastern Daylight Time
https://www.businesswire.com/news/home/20180503006461/en/Applied-DNA-Reports-Fiscal-Quarter-2018-Financial
2Q last year, with slightly better numbers, the pps dropped from $1.50 to about.90 within a month or so (without any real news). If your estimate in on target, we better follow it with significant news and some solid revenue projections in order to avoid the sub-buck depths again.
I sure hope you're wrong.
Razor and blades model
https://en.wikipedia.org/wiki/Razor_and_blades_model
On second thought, maybe intentional.?
Ironic typo in yesterday's PR
“We are grateful to all of our sponsors and to all those now participating in a pre-commercialization, scaled-up pilot trail..."
As in beating a path through rough country I suppose.
http://adnas.com/2018/05/01/apdn-leather-tagging-farm-finished-products/
Been reading SecuringIndustry for many years, here's a first. Supply Chain Traceability with secure, forensic CIJ codes. First ad I've seen for our co-branded printer.
https://www.securingindustry.com/
May 11, 2017 Point of Reference
STONY BROOK, N.Y. (AP) _ Applied DNA Sciences Inc. (APDN) on Thursday reported a loss of $3.4 million in its fiscal second quarter.
The Stony Brook, New York-based company said it had a loss of 13 cents per share.
The DNA-based security technology company posted revenue of $905,373 in the period. Its adjusted revenue was $905,000.
In the final minutes of trading on Thursday, the company's shares hit $1.50. A year ago, they were trading at $3.15.
Time to climb
For your enjoyment.
OEKO-TEX® History as Shadow Play
LEATHER STANDARD by OEKO-TEX®
For Example.
https://www.hohenstein.de/en/certification/oeko_tex/leatherstandard/leatherstandard.xhtml
Big Fish we'll be swimming with next month at Techtextil.
Closing seminar Moderator, Ben Mead (Read: OEKO-TEX)
In his role as Managing Director of Hohenstein Institute Americas, Ben has OEKO-TEX responsibilities for the United States and promotes Hohenstein’s expertise as a globally recognized leader in textile research and testing. He also serves as the company’s liaison with governmental agencies, industry collaborations, and trade associations. Ben previously consulted with a variety of brands and industry associations including Textile Exchange and AFIRM. In those roles, Ben was responsible for content development, training, and establishing partnerships with industry leaders and experts to increase industry engagement in green chemistry and sustainable textile processing. Ben started his career working for Nike, Inc. where he helped develop a restricted substances program and was also involved in implementation of both sustainable materials and water programs. Ben has degrees in Chemistry and Textile Chemistry from North Carolina State University and a certificate in Green Chemistry from the University of Washington.
https://www.hohenstein.de/en/top_services/oeko_tex_2/oeko_tex_3.html
Now those are "Standards" we could better Certify!
Hmmm indeed. We could lock it up a number of ways... If only we live so long.
Another Natural?
During Fiscal Year 2016, the BEP delivered 7.6 billion notes to the Federal Reserve. More than 70 percent of the notes that the BEP delivers each year are used to replace worn notes taken out of circulation.The average cost of a note is 10 cents...
At less than a half cent per note, we would be looking at about $40M recurring...
The BEP is interested in obtaining, testing and evaluating technologies or materials with potential application as a counterfeit deterrent feature in United States currency. Any technologies or materials submitted for consideration will be reviewed for inherent and relative effectiveness as a security feature, compatibility with design and production factors, durability, environmental acceptability and processing requirements. The BEP may submit offered technologies to other technical experts under government contracts for their evaluation subject to the approval of the submitter. The BEP is interested in reviewing all types of products, materials and technologies to address all types of counterfeiting, whether using traditional or new technology. Anti-counterfeiting products of interest include, but are not limited to the following: ink (intaglio, typographic and off-set) and ink additives, alternate and traditional substrates (paper or other medium), substrate additives, design elements or techniques, diffractive, reflective, or otherwise optically variable materials, laminated, or hot-stamped materials.
https://bep.gov/counterfeitdeterrence.html
(Among the first...for what it's worth) I Dream on.
Thanks tag, I've seen this before but this is from the Colorcon link you provided. All this talk of DMFs, are submissions truly required for all existing drugs?
Not so abe. Since our Vandalia Research acquisition in Sept 2015, we've broadened our horizons...
... to minimize lag between payment and use by Colorcon?
My guess is it's a typo. Should have read Applied rather than Advanced DNA Sciences. A quick google search seems to confirm...
"North America is expected to dominate the in vitro diagnostics market in 2018.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to dominate the market followed by Europe. The market in North America is primarily driven by the adoption of fully automated instruments, availability of government funds, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the US.
The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany).
https://www.marketsandmarkets.com/PressReleases/ivd-in-vitro-diagnostics.asp
Happy Anniversary - No news is no news, I would expect some positive surprises next report.
http://adnas.com/2017/04/20/applied-dna-sciences-5-year-supply-agreement-for-bulk-dna-manufacturing/
Not to mention "DNA Made Easy" Large-Scale PCR-Based DNA Production for DNA/RNA vaccines, diagnostics, bioagriculture, gene therapies...
http://adnas.com/easydna/
...Applied DNA Sciences Signs 5-Year Supply Agreement for Bulk DNA Manufacturing... (rev:$500K pa starting 2018)
Plus others?
How Scientists Are Using Plant-Based DNA Barcodes to Bust Counterfeiters
MENTALFLOSS - BY Lucas Reilly February 22, 2018
"Great Article", as tweeted by Barbara Brockway a couple of days ago...
http://mentalfloss.com/article/503061/how-scientists-are-using-plant-based-dna-barcodes-bust-counterfeiters
radical.
And in Amsterdam tomorrow...in-cosmetics(r) global
09:15-How CSI-type forensic science is enabling brands to satisfy consumers' desire for radical transparency. Barbara Brockway, Director of Personal Care. Applied DNA Sciences...
https://www.in-cosmetics.com/en/Sessions/52295/Beyond-natural-New-frontiers-in-green-formulation
(Taking place at RAI Amsterdam, Europaplein 2, 1078 GZ Amsterdam, Netherlands, in-cosmetics Global is the leading global event for personal care ingredients.)
FORMULATIONX
NEW for 2018: Bringing Leading Drug Substance Suppliers and Key Decision Makers Together
The right place at the right time...among others including ACG, Colorcon and DOW.
http://www.interphex.com/en/formulationx/
Tommorrow at INTERPHEX
2:30P:
TECHNICAL CONFERENCE STAGE 4 Quality Metrics and Systems/Risk
On-dose authentication for Tablets and Capsules...
Anyone in NYC able to go?
http://www.interphex.com/RNA/RNA_Interphex_V2/2018/_docs/INTERPHEX-NY-2018-Schedule-At-A-Glance.pdf?v=636590609867564220
Nice to see Janice Meraglia, VP Government & Military Programs evolve, along with our base, into commercial applications. Best of luck next week at INTERPHEX.
And lets not forget Bearings, announced last August as well...
Applied DNA to Begin Production Testing with Major US-based Bearings Manufacturer - Project Aims to Scale-Up Commercial Platform for DNA Marking of Bearings.
Applied DNA to debut security print platform solution
Barcode using our ink, just what the doctor ordered.
http://www.securitydocumentworld.com/article-details/i/13602/